Analysed ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) News Sources
Roche receives FDA approval for companion diagnostic tests to identify patients with HER2-positive metastatic gastroesophageal adenocarcinoma eligible for ZIIHERA
26-08-2026
yahoo.com
Roche expands cyclospora testing portfolio to support U.S. public health response
06-08-2026
yahoo.com
What is the current price of ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS)?
The current price of ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) is $58.47.
ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) since the previous trading day is $1.
ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) since the previous trading day is 1.74%.
What is the most recent average sentiment score for ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS)?
The most recent average sentiment score for ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) is 66 out of 100.
What is the most recent average sentiment for ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS)?
The most recent sentiment for ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS) is .
SEC-8K** Filing Available For ROCHE HOLDINGS LTD-SPONS ADR (RHHBY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.